Provider of kinin pathological services intended for angioedema patients and clinical physicians. The company's offerings include offering expertise to on the kinin-kallikrein system to pharmaceutical companies developing medicines for the treatment of angioedema and diagnostic kits to prevent Angioedema, oedema, adverse reactions of medicines and anaphylactic reactions of transfusion of aphaeresis products, enabling patients to prevent inflammatory diseases.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-Oct-2019 | Completed | Out of Business | |||
1. Accelerator/Incubator | 08-Jun-2015 | Completed | Startup |